SMi has confirmed that Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on the 27th and 28th of April 2017 in London.
With a focus on CRISPR/Cas9 technology, Lorenz’s keynote presentation will explore how this new emerging technique has become an important new approach for drug discovery, particularly in target discovery, hit finding and translational studies. A few key points include:
an overview of PGE and introduction to CRISPR/Cas9 technology
applications in target finding, hit and lead discovery, efficacy and safety models
AstraZeneca’s unique approach towards innovation and collaboration
case studies from AstraZeneca’s drug discovery programmes
future outlook of PGE for drug discovery and therapeutic applications.
Lorenz will be speaking on Day 1 of the conference and joins lead decision-makers and industry innovators from Sanofi, Takeda, Merck Serono, AbbVie, GSK, Johnson & Johnson, UCB Pharma, Eli Lilly and more. A full list of speakers can be found on www.drug-discovery.co.uk.
SMi’s Drug Discovery conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.
The event will also feature two post-conference workshops on new approaches in lead generation and applications of physicochemical and biomimetic properties in early drug discovery.
For more details about the conference and registration information, visit www.drug-discovery.co.uk.
DRUG DISCOVERY
27 – 28 MARCH 2017
Holiday Inn Kensington Forum
www.drug-discovery.co.uk
---end ---
Contact Information:
For sponsorship and exhibition queries please contact Alia Malick at [email protected]. For delegate queries please contact Fateja Begum at [email protected]. For media queries please contact Honey de Gracia at [email protected].
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk